In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
Authors
Keywords
-
Journal
MOLECULAR DIVERSITY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-26
DOI
10.1007/s11030-021-10215-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing
- (2020) Bei Li et al. mSphere
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir: Review of pharmacology, pre‐clinical data and emerging clinical experience for COVID‐19
- (2020) Sarah CJ Jorgensen et al. PHARMACOTHERAPY
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- Chemistry and Biology of SARS-CoV-2
- (2020) Alexander Dömling et al. Chem
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
- (2020) Maria Romano et al. Cells
- A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
- (2020) Sabari Nath Neerukonda et al. Pathogens
- Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2
- (2020) Deepak S. Chauhan et al. BIOCONJUGATE CHEMISTRY
- COVID19 inhibitors: A prospective therapeutics
- (2020) Md Jawaid Akhtar BIOORGANIC CHEMISTRY
- Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
- (2020) Vankudavath Raju Naik et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation
- (2020) Pallab Kar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target
- (2020) Yanyan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
- (2020) Minchen Chien et al. JOURNAL OF PROTEOME RESEARCH
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics
- (2020) Ramesh Kandimalla et al. MOLECULAR NEUROBIOLOGY
- Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID‐19) and the rationale for their utilization: A review
- (2020) Richard A. Giovane et al. REVIEWS IN MEDICAL VIROLOGY
- Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
- (2020) Jennifer Santos et al. Viruses-Basel
- Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics
- (2020) Mubarak A. Alamri et al. Arabian Journal of Chemistry
- A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
- (2020) Seyed MohammadReza Hashemian et al. Drug Design Development and Therapy
- High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
- (2020) Biswajit Naik et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
- (2020) Anna Artese et al. DRUG RESISTANCE UPDATES
- In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases
- (2018) Manne Munikumar et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Prodrug approach: An overview of recent cases
- (2017) Valentina Abet et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis
- (2013) Vani Priyadarshini et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC ofLeptospiraspp.: homology modeling, docking, and molecular dynamics study
- (2013) Dibyabhaba Pradhan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- An overview of the Amber biomolecular simulation package
- (2012) Romelia Salomon-Ferrer et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- Improved side-chain torsion potentials for the Amber ff99SB protein force field
- (2010) Kresten Lindorff-Larsen et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan
- (2009) Gopal C. Ghosh et al. ENVIRONMENTAL HEALTH PERSPECTIVES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started